Novavax Inc. stock underperforms Wednesday when compared to competitors | news.google.com • |
Shah Capital Management Acquires 1,544,263 Shares of Novavax, Inc. (NASDAQ:NVAX) | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Why Novavax is Gaining Ground in COVID-19 Vaccine Race | zacks.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | 1.82 | 0.99 | -0.83 | -45.60% |
2024-05-10 | 2024-03 | -1.04 | -1.05 | -0.01 | -0.96% |
2024-02-28 | 2023-12 | -0.49 | -1.44 | -0.95 | -193.88% |
2023-11-09 | 2023-09 | -1.82 | -1.26 | 0.56 | 30.77% |
2023-08-08 | 2023-06 | -1.24 | 0.58 | 1.82 | 146.77% |
2023-05-09 | 2023-03 | -3.38 | -3.41 | -0.03 | -0.89% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-08 | B. Riley Securities | Upgrade | Neutral | Buy |
2023-05-09 | HC Wainwright & Co. | Upgrade | Buy | |
2023-02-28 | B. Riley Securities | Downgrade | Buy | Neutral |
2023-02-12 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-01 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-06-11 | ALTON GREGG H | Director | 10.47K | Conversion of Exercise of derivative security |
2024-06-11 | DOUGLAS RICHARD H | Director | 43.92K | Conversion of Exercise of derivative security |
2024-06-16 | DUBOVSKY FILIP | Officer | 66.61K | Sale |
2024-08-15 | KELLY JAMES PATRICK | Chief Financial Officer | 14.43K | Conversion of Exercise of derivative security |
2024-06-11 | KING RACHEL K | Director | 18.92K | Conversion of Exercise of derivative security |
2024-06-11 | MCGLYNN MARGARET G | Director | 10.47K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | State Street Corporation | 11.68M | 86.78M | 12.37% |
2023-06-29 | Vanguard Group Inc | 10.57M | 78.55M | 11.20% |
2023-06-29 | Blackrock Inc. | 6.99M | 51.97M | 7.41% |
2023-09-29 | Shah Capital Management | 6.33M | 45.83M | 6.71% |
2023-06-29 | Bank of America Corporation | 2.18M | 16.23M | 2.31% |
2023-06-29 | Morgan Stanley | 2.08M | 15.46M | 2.20% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 9.38M | 75.07M | 9.94% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.64M | 19.60M | 2.79% |
2023-06-29 | Vanguard Small-Cap Index Fund | 2.23M | 16.56M | 2.36% |
2023-08-30 | iShares Russell 2000 ETF | 2.01M | 16.10M | 2.13% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 1.28M | 9.48M | 1.35% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.21M | 8.98M | 1.28% |
Split | Date |
---|---|
1 : 20 | 2019-05-10 |
-
I feel that $80 will be the turn around if there is one
-
$NVAX I spy some new positions!
https://finance.yahoo.com/news/selective-wealth-management-inc-buys-183830692.html
-
$NVAX In the market someone has to win and someone has to lose. But when shorts wreck a good thing on purpose, it secures their place in hell. Don’t forget we play a part too. They can only buy back at the lower prices if we sell to them.
-
For those of you who think $NVAX missed the party that $PFE and $MRNA came early to, you don’t understand that those are gene therapies. A traditional vaccine takes time to produce. We were there testing flu/covid combo shots when Fauci shut down the country to push his gene therapies and we are here now with the slow baked product. (You do know NIH owns 1/2 the Moderna patent Im sure.) It’s time, This is the real deal, not a crap shoot in the dark. If you had the gene therapies that don’t work, you can get the Novavax vaccine and stop the booster experiment.
-
$NVAX Soooo The Supreme Court blocked a tyrannical mandate that was never in place to begin with. So where’s the fire? Many people still want vaccines. This selloff is an over reaction and shorts are going to eat up the shares down to zero if we keep selling.
-
-
The answer is institution bulls have left the NVAX game and this gives control to hedge fund shorts. Good news do not attract whales anymore. This has nothing to do with science or cash flow or sales. This is just price action beyond the control of retail investors or retail shorts.
-
-
It’s over , this is the last bullet.
-
Do not sell shorts like to play weekly options. Tomorrow expiration.
-
$NVAX Correction, tomorrow is Options expiration. This program has wrong dates.
-
$NVAX The bleeding should stop today, OPTIONS EXPIRATION. Shorts working hard to keep price below $125.50 today. Otherwise no news on reason for drop. Tomorrow should be better. Stop selling to shorts at these prices allowing them to load up and short again. I am buying dip today.
-
It’s a joke
-
$NVAX Don’t panic sell. The shorts cycle through these stocks. We have shortable shares, till we don’t or more good news drops. Sorry about the quality of pic can’t get on phone.
-
-
$NVAX Looks like $125.50 price is where they want to keep it till tomorrow so they will short to avoid getting assigned on the calls they wrote. We will be back Monday.
-
$NVAX Looks like $125.50 price is where they want to keep it till tomorrow so they will short to avoid getting assigned on the calls they wrote. We will be back Monday.
-
$NVAX Don’t panic sell. They short at options expiration so they don’t lose on the calls they wrote. Lots of shorts this morning. It will be back Monday and the Monday after that.
-
AI Y, Aren’t you shorting too. Mr. Pumper and Dumper.
-
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Tuesday when compared to competitors
news.google.com • -
Why Novavax is Gaining Ground in COVID-19 Vaccine Race
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Monday when compared to competitors
news.google.com • -
(NVAX) Trading Report
news.google.com • -
Novavax Inc. stock outperforms competitors on strong trading day
news.google.com • -
Should You Buy Novavax Stock After This Regulatory Win?
news.google.com • -
Should You Buy Novavax Stock After This Regulatory Win?
news.google.com • -
Novavax Inc. stock underperforms Thursday when compared to competitors
news.google.com • -
Why Are Novavax Shares Trading Lower Today?
news.google.com • -
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax, Inc. (NVAX) Baird 2024 Global Healthcare Conference (Transcript)
seekingalpha.com • -
Novavax to Participate in Upcoming September Conferences
prnewswire.com • -
Novavax: Staying Long Despite Coming Up Short In Q2
seekingalpha.com • -
Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
marketbeat.com • -
Novavax, Inc. (NVAX) Q2 2024 Earnings Call Transcript
seekingalpha.com •